{"nctId":"NCT01082367","briefTitle":"Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years","startDateStruct":{"date":"2010-04"},"conditions":["Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients"],"count":50,"armGroups":[{"label":"TOBI (tobramycin inhaled solution)/Placebo","type":"EXPERIMENTAL","interventionNames":["Drug: TOBI","Drug: Placebo"]},{"label":"Placebo/TOBI","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: TOBI","Drug: Placebo"]}],"interventions":[{"name":"TOBI","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of cystic fibrosis\n* Early lower respiratory tract infection with P. aeruginosa,\n\nExclusion Criteria:\n\n* Known local or systemic hypersensitivity to aminoglycosides or inhaled antibiotics.\n* Administration of loop diuretics within 7 days prior to study drug administration.\n* Other protocol-defined inclusion/exclusion criteria may apply","healthyVolunteers":false,"sex":"ALL","minimumAge":"3 Months","maximumAge":"6 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants P Aeruginosa-free After Completion of the First Treatment Cycle","description":"Sputum/throat swab cultures were assessed.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"84.6","spread":null},{"groupId":"OG001","value":"24.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Free From P. Aeruginosa 28 Days After Termination of the Second Treatment Cycle","description":"Sputum/throat swab cultures were assessed.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"92.3","spread":null},{"groupId":"OG001","value":"83.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants P Aeruginosa-free at Termination of the Double Blind Period","description":"Sputum/throat swab cultures were assessed.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"76.0","spread":null},{"groupId":"OG001","value":"47.8","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":32},"commonTop":["Cough","Pyrexia","Rhinorrhoea","Vomiting","Ear infection"]}}}